Every year many newborns, especially those born early, underweight or sick, face neonatal hypoglycemia. This is a dangerous drop in blood sugar that can cause seizures, brain injury and long-term development problems if it is not found and treated quickly.
Researchers at the Rice360 Institute published a study in BMC Pediatrics and tested 11 commonly available point-of-care glucometers. In the laboratory they changed adult blood samples to match newborn glucose and hematocrit ranges. The tests showed that several low-cost glucometers gave reliable readings at neonatal ranges, which could help hospitals that cannot afford special neonatal meters.
Difficult words
- neonatal — Related to the first days after birth.
- hypoglycemia — A dangerous low level of blood sugar.
- glucometer — A device that measures blood sugar quickly.glucometers
- hematocrit — The percentage of red blood cells in blood.
- seizure — Sudden, uncontrolled brain activity causing shaking.seizures
- reliable — Can be trusted to give correct results.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is it important to check a newborn's blood sugar?
- Do you think low-cost reliable glucometers could help small hospitals? Why or why not?
- What should doctors do if a newborn has hypoglycemia?
Related articles
Which childhood food allergies are outgrown?
Many children outgrow milk and egg allergies, while peanut, tree nut, sesame and shellfish allergies often persist. Factors such as IgE levels, allergy severity and genetics affect whether a child becomes tolerant and which treatments help.
People learn to use robotic leg prostheses but misjudge their gait
A four-day study found that people who practised with a robotic lower‑limb prosthesis improved their walking but misjudged their own movement. Researchers say better visual feedback could help users calibrate their body image and gait.
New PET study links brain markers in Parkinson’s disease
Researchers used PET scans to compare two brain markers — dopamine transporters and synaptic density — in people with Parkinson’s and healthy volunteers. The study shows the usual link between markers breaks down in Parkinson’s.
